Curious how tesamorelin, a well-studied visceral fat peptide, is helping investigators probe VAT biology and cardiometabolic risk? This review unpacks its GHRH-driven mechanism, key data from HIV-associated lipodystrophy, and how scientists deploy tesamorelin across preclinical and clinical studies.
More
Updating…